JNJ vs TNC · P/E 17, rev $49.37B vs P/E 51, rev $621.9M
Johnson & Johnson (JNJ) versus Tennant Company (TNC) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Tennant Company (TNC) is a specialty industrial machinery company listed on NYSE.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TNC revenue for 2026-06-30 was $621.9M. Net income was $7.8M. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TNC currently screens at market cap $1.46B and trailing P/E 51.1.
Not investment advice. Open the JNJ and TNC stock pages for the full models.
Not investment advice.